Can't find what you're looking for?
View all search resultsCan't find what you're looking for?
View all search resultsNeuralink said clearance from the US Food and Drug Administration (FDA) for its first in-human clinical study is "an important first step" for its technology, which is intended to let brains interface directly with computers.
This video screen grab made from Tesla AI Day 2022 livestream shows Elon Musk standing on stage next to Optimus the humanoid robot in Palo Alto, California on September 30, 2022. Elon Musk presented on September 30, 2022 a prototype of the humanoid robot Optimus, which his company Tesla hopes to produce one day by “millions“ to “transform civilization“ and build a “future of abundance“ where poverty will be gone. (AFP/Tesla)
Elon Musk's start-up Neuralink on Thursday said it has approval from US regulators to test its brain implants in people.
Neuralink said clearance from the US Food and Drug Administration (FDA) for its first in-human clinical study is "an important first step" for its technology, which is intended to let brains interface directly with computers.
"We are excited to share that we have received the FDA's approval to launch our first-in-human clinical study," Neuralink said in a post on Musk-run Twitter.
Recruitment for a clinical trial is not yet open, according to Neuralink.
The aim of Neuralink implants is to enable human brains to communicate directly with computers, Musk said during a presentation by the start-up in December.
"We've been working hard to be ready for our first human (implant), and obviously we want to be extremely careful and certain that it will work well before putting a device in a human," he said at the time.
Neuralink prototypes, which are the size of a coin, have been implanted in the skulls of monkeys, demonstrations by the startup showed.
Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.
Thank you for sharing your thoughts. We appreciate your feedback.
Quickly share this news with your network—keep everyone informed with just a single click!
Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
Get the best experience—faster access, exclusive features, and a seamless way to stay updated.